相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
David A. Lipson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
Nicola C. Day et al.
RESPIRATORY RESEARCH (2020)
Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors
Ram Jagannathan et al.
CURRENT DIABETES REPORTS (2019)
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
Steven Pascoe et al.
LANCET RESPIRATORY MEDICINE (2019)
Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis
Hyun Woo Lee et al.
PLOS MEDICINE (2019)
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events
Ken M. Kunisaki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Alberto Papi et al.
LANCET (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Anne Y. Gedebjerg et al.
LANCET RESPIRATORY MEDICINE (2018)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
Kyle J. Foreman et al.
LANCET (2018)
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
I. D. Pavord et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Missing data in clinical trials: control-based mean imputation and sensitivity analysis
Devan V. Mehrotra et al.
PHARMACEUTICAL STATISTICS (2017)
The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy
Mirko Di Martino et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Understanding disease mechanisms at the nanoscale: endothelial apoptosis and microparticles in COPD
Tom Wilkinson
THORAX (2016)
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease
Martin I. MacDonald et al.
LANCET RESPIRATORY MEDICINE (2016)
Cell-derived microparticles and the lung
Dario Nieri et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Global and regional trends in COPD mortality, 1990-2010
Peter G. J. Burney et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease
Maria Gabriella Matera et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials
Steven Pascoe et al.
LANCET RESPIRATORY MEDICINE (2015)
Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
Michelle T. Harrison et al.
THORAX (2014)
Annual FEV1 changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study
Toru Takahashi et al.
BMJ OPEN (2014)
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
Alvar Agusti et al.
PLOS ONE (2012)
Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility
Toru Takahashi et al.
THORAX (2012)
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Gavin C. Donaldson et al.
CHEST (2010)
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
T. M. L. Eagan et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
Bartolome Celli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease A Randomized Trial
Therese S. Lapperre et al.
ANNALS OF INTERNAL MEDICINE (2009)
Outcomes for COPD pharmacological trials:: from lung function to biomarkers
M. Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
From COPD to chronic systemic inflammatory syndrome?
Leonardo M. Fabbri et al.
LANCET (2007)
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD
Daiana Stolz et al.
CHEST (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inflammatory changes, recovery and recurrence at COPD exacerbation
W. R. Perera et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease
DD Sin et al.
THORAX (2005)
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
JJ Soler-Cataluña et al.
THORAX (2005)
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
NR Anthonisen et al.
ANNALS OF INTERNAL MEDICINE (2005)
Mortality in relation to smoking: 50 years' observations on male British doctors
R Doll et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Systemic effects of chronic obstructive pulmonary disease
AGN Agustí et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
JB Soriano et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease
DD Sin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
分享论文
